Increased TNFα can attenuate NF-κB activity in wogonin exposed leukemic cells and fisetin treatment in bladder cancer induces apoptosis through inhibition of NF-κB pathway [47,48]. The gene discussed is NFKB1; the disease is urinary bladder carcinoma.